[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:mixed-phenotype-acute-leukemia":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":236,"states":252},"Mixed Phenotype Acute Leukemia",37,33,[8,16,23,30,37,44,50,56,62,68,74,80,86,91,97,103,109,115,121,127,133,139,145,151,157,163,168,174,180,186,192,198,204,210,217,224,230],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07222579","Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)",[12],"Phase 2","RECRUITING","2026-08-26T02:17:02.694423Z","2026-05-05T02:43:29.054327Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05360160","A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine\u002FCedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)",[20],"Phase 1\u002FPhase 2","2026-08-26T02:18:01.700186Z","2026-05-05T02:43:29.040577Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT06448013","A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia",[27],"Phase 1","2026-08-26T02:19:19.162260Z","2026-05-05T02:43:27.592833Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":35,"content_modified":36},"NCT03959085","Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy",[34],"Phase 3","2026-08-26T02:18:17.950264Z","2026-07-05T03:45:20.447682Z",{"nct_id":38,"title":39,"phases":40,"status":13,"updated_at":42,"content_modified":43},"NCT06289673","Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia\u002FLymphoma",[41],"Phase 4","2026-08-26T02:19:19.975067Z","2026-05-05T02:43:29.703791Z",{"nct_id":45,"title":46,"phases":47,"status":13,"updated_at":48,"content_modified":49},"NCT07216443","Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome",[12],"2026-08-26T02:19:27.519777Z","2026-05-05T02:43:29.533990Z",{"nct_id":51,"title":52,"phases":53,"status":13,"updated_at":54,"content_modified":55},"NCT06390319","Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)",[12],"2026-08-26T02:18:39.640967Z","2026-05-05T02:43:28.653429Z",{"nct_id":57,"title":58,"phases":59,"status":13,"updated_at":60,"content_modified":61},"NCT04872478","Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed\u002FRefractory AML, ALL, or MPAL",[27],"2026-08-26T02:16:03.788292Z","2026-05-05T02:43:28.121189Z",{"nct_id":63,"title":64,"phases":65,"status":13,"updated_at":66,"content_modified":67},"NCT05101551","Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy",[27],"2026-08-26T02:17:52.450442Z","2026-05-05T02:43:28.076554Z",{"nct_id":69,"title":70,"phases":71,"status":13,"updated_at":72,"content_modified":73},"NCT04187105","BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)",[12],"2026-08-26T02:17:44.240289Z","2026-05-05T02:43:27.748653Z",{"nct_id":75,"title":76,"phases":77,"status":13,"updated_at":78,"content_modified":79},"NCT07356154","A Study of Revumenib and Mezigdomide in People With Leukemia",[20],"2026-08-26T02:16:18.872924Z","2026-05-05T02:43:26.921862Z",{"nct_id":81,"title":82,"phases":83,"status":13,"updated_at":84,"content_modified":85},"NCT04797767","Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms",[20],"2026-08-26T02:18:15.214990Z","2026-04-29T02:57:57.089926Z",{"nct_id":87,"title":88,"phases":89,"status":13,"updated_at":66,"content_modified":90},"NCT03670966","211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome",[20],"2026-07-05T05:32:16.772513Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT06928662","Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse",[20],"2026-08-26T02:16:39.977107Z","2026-07-05T05:32:16.705622Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT04318678","CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)",[27],"2026-08-26T02:17:50.500039Z","2026-05-05T02:43:29.730542Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT03810196","CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ\u002FCD19 Depleted HSCT",[],"2026-08-26T02:16:54.044282Z","2026-05-05T02:43:29.362818Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT06680661","ABBA CORD: dCBT w\u002F Abatacept for aGVHD Prophylaxis",[12],"2026-08-26T02:17:14.343713Z","2026-05-05T02:43:28.824003Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT04249830","Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults",[],"2026-08-26T02:18:17.007929Z","2026-05-05T02:43:28.641599Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT03802695","A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies",[27],"2026-08-26T02:19:03.581490Z","2026-05-05T02:43:27.946302Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT03326921","HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant",[27],"2026-08-26T02:19:00.742020Z","2026-05-05T02:43:27.769481Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":137,"content_modified":138},"NCT05476770","Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies",[27],"2026-08-26T02:17:16.980188Z","2026-05-05T02:43:27.744798Z",{"nct_id":140,"title":141,"phases":142,"status":13,"updated_at":143,"content_modified":144},"NCT03128034","211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia",[20],"2026-08-26T02:17:30.961790Z","2026-05-05T02:43:27.480643Z",{"nct_id":146,"title":147,"phases":148,"status":13,"updated_at":149,"content_modified":150},"NCT04195633","Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies",[12],"2026-08-26T02:17:07.954622Z","2026-05-05T02:43:27.479357Z",{"nct_id":152,"title":153,"phases":154,"status":13,"updated_at":155,"content_modified":156},"NCT06533579","Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)",[20],"2026-08-26T02:17:58.890423Z","2026-05-05T02:43:27.324190Z",{"nct_id":158,"title":159,"phases":160,"status":13,"updated_at":161,"content_modified":162},"NCT05011422","Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha\u002FBeta and CD19 Depletion in Pediatric Hematologic Malignancies",[27],"2026-08-26T02:18:22.309547Z","2026-05-05T02:43:27.284218Z",{"nct_id":164,"title":165,"phases":166,"status":13,"updated_at":78,"content_modified":167},"NCT03779854","Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant",[12],"2026-05-05T02:43:27.279311Z",{"nct_id":169,"title":170,"phases":171,"status":13,"updated_at":172,"content_modified":173},"NCT04065399","A Study of Revumenib in R\u002FR Leukemias Including Those With an MLL\u002FKMT2A Gene Rearrangement or NPM1 Mutation",[20],"2026-08-26T02:18:48.678868Z","2026-05-05T02:43:27.111185Z",{"nct_id":175,"title":176,"phases":177,"status":13,"updated_at":178,"content_modified":179},"NCT06397027","A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias",[27],"2026-08-26T02:16:17.877565Z","2026-05-05T02:43:27.100920Z",{"nct_id":181,"title":182,"phases":183,"status":13,"updated_at":184,"content_modified":185},"NCT06551584","Phase I Trial for Patients w\u002F Advanced Hematologic Malignancies Undergoing Allogeneic HCT",[27],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:26.766329Z",{"nct_id":187,"title":188,"phases":189,"status":13,"updated_at":190,"content_modified":191},"NCT06326463","CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies",[27],"2026-08-26T02:17:33.807405Z","2026-05-05T02:35:31.873958Z",{"nct_id":193,"title":194,"phases":195,"status":13,"updated_at":196,"content_modified":197},"NCT06926595","Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention",[12],"2026-08-26T02:19:22.562392Z","2026-05-05T02:35:31.707594Z",{"nct_id":199,"title":200,"phases":201,"status":13,"updated_at":202,"content_modified":203},"NCT04726241","The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study",[20],"2026-08-26T02:18:33.598205Z","2026-05-05T02:43:29.704606Z",{"nct_id":205,"title":206,"phases":207,"status":13,"updated_at":208,"content_modified":209},"NCT05929976","InterNatIonal CHildhood Leukemia Microbiome\u002FMEtabolome Cohort",[],"2026-08-26T02:15:29.632183Z","2026-05-13T02:55:06.394913Z",{"nct_id":211,"title":212,"phases":213,"status":214,"updated_at":215,"content_modified":216},"NCT07008027","Real World Asparaginase Therapy Toxicity",[],"NOT_YET_RECRUITING","2026-08-26T02:17:28.381459Z","2026-05-13T02:55:06.605227Z",{"nct_id":218,"title":219,"phases":220,"status":221,"updated_at":222,"content_modified":223},"NCT04872790","Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia",[27],"ACTIVE_NOT_RECRUITING","2026-08-03T02:32:04.757108Z","2026-05-05T02:43:26.960917Z",{"nct_id":225,"title":226,"phases":227,"status":221,"updated_at":228,"content_modified":229},"NCT05088356","Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w\u002FT-Cell Depleted Graft",[27],"2026-08-03T03:40:48.829801Z","2026-05-05T02:43:28.470053Z",{"nct_id":231,"title":232,"phases":233,"status":221,"updated_at":234,"content_modified":235},"NCT05602194","Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma",[34],"2026-08-03T02:14:31.240767Z","2026-05-05T02:35:31.762991Z",[237,241,245,248],{"biomarker":238,"count":239,"slug":240},"KMT2A Gene",6,"kmt2a-gene",{"biomarker":242,"count":243,"slug":244},"NPM1 Gene",5,"npm1-gene",{"biomarker":246,"count":243,"slug":247},"NUP98 Gene","nup98-gene",{"biomarker":249,"count":250,"slug":251},"HLA Complex",3,"hla-complex",[253,257,261,264,268,271,275,279,282,285,289,292,296,299,302,305,308,311,314,317,320,323,326,330],{"state":254,"count":255,"slug":256},"California",16,"california",{"state":258,"count":259,"slug":260},"Tennessee",12,"tennessee",{"state":262,"count":259,"slug":263},"Washington","washington",{"state":265,"count":266,"slug":267},"New York",11,"new-york",{"state":269,"count":266,"slug":270},"Texas","texas",{"state":272,"count":273,"slug":274},"Ohio",10,"ohio",{"state":276,"count":277,"slug":278},"North Carolina",9,"north-carolina",{"state":280,"count":277,"slug":281},"Oregon","oregon",{"state":283,"count":277,"slug":284},"Pennsylvania","pennsylvania",{"state":286,"count":287,"slug":288},"Florida",8,"florida",{"state":290,"count":287,"slug":291},"Georgia","georgia",{"state":293,"count":294,"slug":295},"New Jersey",7,"new-jersey",{"state":297,"count":239,"slug":298},"Colorado","colorado",{"state":300,"count":239,"slug":301},"Illinois","illinois",{"state":303,"count":239,"slug":304},"Wisconsin","wisconsin",{"state":306,"count":243,"slug":307},"District of Columbia","district-of-columbia",{"state":309,"count":243,"slug":310},"Iowa","iowa",{"state":312,"count":243,"slug":313},"Massachusetts","massachusetts",{"state":315,"count":243,"slug":316},"Minnesota","minnesota",{"state":318,"count":243,"slug":319},"Missouri","missouri",{"state":321,"count":243,"slug":322},"Oklahoma","oklahoma",{"state":324,"count":243,"slug":325},"Utah","utah",{"state":327,"count":328,"slug":329},"Arizona",4,"arizona",{"state":331,"count":328,"slug":332},"Arkansas","arkansas"]